vimarsana.com

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Related Keywords

California ,United States ,Boston ,Massachusetts ,Pacific Biosciences ,Kingwin Ltd ,Argo Blockchain ,Lumiradx Limited ,Quantasing Group Limited ,Ambrx Biopharma Inc ,Biocryst Pharmaceuticals Inc ,California Inc ,Solo Brands Inc ,Nasdaq ,Boston Scientific ,Bright Health Group Inc ,Spirit Aerosystems ,Axonics Inc ,Elevation Oncology Inc ,Avadel Pharmaceuticals ,Green Development Corporation ,Health Inc ,Fastly Inc ,Universe Pharmaceuticals ,Vincerx Pharma Inc ,Johnson ,Nkarta Inc ,Rxsight Inc ,Cyclacel Pharmaceuticals Inc ,Banzai International Inc ,Butterfly Network Inc ,Arena Group Holdings Inc ,Spirit Aerosystems Holdings Inc ,Veterinary Partners Inc ,Biosig Technologies Inc ,Ardelyx Inc ,Prothena Corporation ,Spectaire Holdings Inc ,Shattuck Labs Inc ,Sharps Technology Inc ,Lendingtree Inc ,Jin Medical International Ltd ,Crocs Inc ,Shuttle Pharmaceuticals ,Northern Dynasty Minerals Ltd ,Praxis Precision Medicines Inc ,University Of Pennsylvania ,Venus Concept Inc ,Mmtec Inc ,Ampio Pharmaceuticals Inc ,Neximmune Inc ,Revance Therapeutics Inc ,Upwork Inc ,Wolverine World Wide Inc ,Us District Court ,Harpoon Therapeutics Inc ,Shuttle Pharmaceuticals Holdings Inc ,Precision Medicines ,Cryst Pharmaceuticals ,World Wide ,Road Medical ,Sector Perform ,Arena Group Holdings ,Veterinary Partners ,Sig Technologies ,Biosig Technologies ,Nasdaq Listing Rule ,Health Group ,Green Development ,Pharmaceuticals Holdings ,Aerosystems Holdings ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.